Sept 15 (Reuters) – Vivesto AB: * ANNOUNCES POSITIVE TOPLINE RESULTS FOR PACCAL VET IN DOGS WITH SPLENIC HEMANGIOSARCOMA * PACCAL VET RESULTED IN A MEDIAN OVERALL SURVIVAL OF 135 DAYS IN DOGS WITH
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
LONDON, Nov 2 (Reuters) - Global asset manager Apollo launched a €10 billion ($11.2 billion)…
STOCKHOLM, Nov 2 (Reuters) - The temperature of freezers at several Swedish grocery stores rose…
Nov 2 (Reuters) - FCA: * FCA: REVIEW TO EXAMINE IF FCA MET ITS RESPONSIBILITIES…
LONDON, Nov 2 (Reuters) - Global asset manager Apollo launched a €10 billion ($11.2 billion)…
Nov 2 (Reuters) - SpaceX is in talks to buy EchoStar's wireless service Boost Mobile…
Nov 2 (Reuters) - SpaceX is in talks to buy EchoStar's wireless service Boost Mobile…